Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangdun Choi

Showing results (21-30 of 197) with videos related to

Pageof 20
Sort By:
Archives of Pharmacal Research|January 22, 2010
Drugs targeting Toll-like receptorsJayalakshmi Krishnan, Gwang Lee, Sangdun Choi
Frontiers in Physiology|August 17, 2011
Similar Structures but Different Roles - An Updated Perspective on TLR StructuresBalachandran Manavalan, Shaherin Basith, Sangdun Choi
Biochemical Pharmacology|January 22, 2026
Structural and molecular characterization of a small-molecule TNF-α-TNFR1 inhibitor modulating cell death signalingHana Seo, Muhammad Haseeb, Sangdun Choi
Pharmaceutics|September 5, 2019
Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery MethodsNasir Javaid, Farzana Yasmeen, Sangdun Choi
Medicinal Research Reviews|July 21, 2021
Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptorsMaria Batool, Moon Suk Kim, Sangdun Choi
RSC Advances|May 6, 2022
Structural mechanism of DNA-mediated Nanog-Sox2 cooperative interactionDhanusha Yesudhas, Muhammad Ayaz Anwar, Sangdun Choi
Experimental & Molecular Medicine|February 23, 2013
Negative regulatory approaches to the attenuation of Toll-like receptor signalingMuhammad Ayaz Anwar, Shaherin Basith, Sangdun Choi
Frontiers in Immunology|December 14, 2018
Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic ImplicationsMuhammad Haseeb, Muhammad Ayaz Anwar, Sangdun Choi
Expert Opinion on Therapeutic Patents|November 24, 2015
The triumph of chemically enhanced cellular reprogramming: a patent reviewMuhammad Ayaz Anwar, Songmee Kim, Sangdun Choi
Expert Opinion on Drug Discovery|September 8, 2016
Toll-like receptors targeting technology for the treatment of lymphomaMaria Batool, Muhammad Ayaz Anwar, Sangdun Choi
Pageof 20

Showing results (21-30 of 197) with videos related to

Sort By:
Pageof 20
Archives of Pharmacal Research|January 22, 2010
Drugs targeting Toll-like receptorsJayalakshmi Krishnan, Gwang Lee, Sangdun Choi
Frontiers in Physiology|August 17, 2011
Similar Structures but Different Roles - An Updated Perspective on TLR StructuresBalachandran Manavalan, Shaherin Basith, Sangdun Choi
Biochemical Pharmacology|January 22, 2026
Structural and molecular characterization of a small-molecule TNF-α-TNFR1 inhibitor modulating cell death signalingHana Seo, Muhammad Haseeb, Sangdun Choi
Pharmaceutics|September 5, 2019
Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery MethodsNasir Javaid, Farzana Yasmeen, Sangdun Choi
Medicinal Research Reviews|July 21, 2021
Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptorsMaria Batool, Moon Suk Kim, Sangdun Choi
RSC Advances|May 6, 2022
Structural mechanism of DNA-mediated Nanog-Sox2 cooperative interactionDhanusha Yesudhas, Muhammad Ayaz Anwar, Sangdun Choi
Experimental & Molecular Medicine|February 23, 2013
Negative regulatory approaches to the attenuation of Toll-like receptor signalingMuhammad Ayaz Anwar, Shaherin Basith, Sangdun Choi
Frontiers in Immunology|December 14, 2018
Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic ImplicationsMuhammad Haseeb, Muhammad Ayaz Anwar, Sangdun Choi
Expert Opinion on Therapeutic Patents|November 24, 2015
The triumph of chemically enhanced cellular reprogramming: a patent reviewMuhammad Ayaz Anwar, Songmee Kim, Sangdun Choi
Expert Opinion on Drug Discovery|September 8, 2016
Toll-like receptors targeting technology for the treatment of lymphomaMaria Batool, Muhammad Ayaz Anwar, Sangdun Choi
Pageof 20